Reference
Lim JR, Faught PR, Chalasani NP, et al. Severe liver injury after initiating therapy with atomoxetine in two children. J Pediatr 2006 Jun; 148(6): 831–4
Roncalli J, Delord JP, Galinier M, et al. Bevacizumab in metastatic colorectal cancer: a left intracardiac thrombotic event. Ann Oncol 2006 Jul; 17(7): 1177–8
Lordick F, Geinitz H, Theisen J, et al. Increased risk of ischemic bowel complications during treatment with bevacizumab after pelvic irradiation: report of three cases. Int J Radiat Oncol Biol Phys 2006 Apr 1; 64(5): 1295–8
Espinós J, Rifón J, Pérez-Calvo J, et al. Idiopathic hyperammonemia following high-dose chemotherapy. Bone Marrow Transplant 2006 May; 37(9): 899
Haj MA, Murch N, Bowen DJ, et al. Cefotaxime as the potential cause of transient acquired von Willebrand syndrome. Eur J Haematol 2006 May; 76(5): 40–3
Ghori F, Polder KD, Pinter-Brown LC, et al. Thyrotoxicosis after denileukin diftitox therapy in patients with mycosis fungoides. J Clin Endocrinol Metab 2006 Jun; 91(6): 2205–8
Cameron C. Serotonin syndrome precipitated by an over-the-counter cold remedy. Aust Prescr 2006 Jun; 29(3): 71
Carter JD, Valeriano J, Vasey FB. Tumor necrosis factor-α inhibition and VATER association: a causal relationship? J Rheumatol 2006 May; 33(5): 1014–7
Aksu K, Donmez A, Ertan Y, et al. A case with ankylosing spondylitis, developing Hodgkin’s disease following treatment with etanercept [abstract no. AB0296]. Annual European Congress of Rheumatology; 2006 Jun 21–24; Amsterdam
Hallberg P, Martén L, Wadelius M. Possible fluconazole-fentanyl interaction: a case report. Eur J Clin Pharmacol 2006 Jun; 62(6): 491–2
Audimoolam VK, Bhandari S. Acute interstitial nephritis induced by glucosamine. Nephrol Dial Transplant 2006 Jul; 21(7): 31
Scollard DM, Joyce MP, Gillis TP. Development of leprosy and type 1 leprosy reactions after treatment with infliximab: a report of 2 cases. Clin Infect Dis 2006 Jul 15; 43(2): e19–22
Thonhofer R, Kriessmayr M, Thonhofer U, et al. RA-patients with therapy induced MDS present with long-time remission after recovery: a report of two cases [abstract no. SAT0137]. Ann Rheum Dis 2006 Jul; Suppl. II: 490-1
Leong DP, Kleinig TJ, Kimber TE, et al. Severe hypermagnesaemia related to laxative use in acute gastrointestinal graft-versus-host disease. Bone Marrow Transplant 2006 Jul; 38(1): 71–2
Zippel D, Urbanski S, Sutherland F. Quicksilver cholecystitis. Ann Intern Med 2006 Jun 20; 144(12): 941
Zink M, Knopf U, Argiriou S, et al. A case of pulmonary thromboembolism and rhabdomyolysis during therapy with mirtazapine and risperidone. J Clin Psychiatry 2006 May; 67(5): 835
Ganetsky M, Bird SB, Liang IE. Acute myocardial infarction associated with the serotonin syndrome. Ann Intern Med 2006 May 16; 144(10): 782–3
Dhalla MS, Blinder KJ, Tewari A, et al. Retinal pigment epithelial tear following intravitreal pegaptanib sodium. Am J Ophthalmol 2006 Apr; 141(4): 752–4
Wartenberg KE, Parra A. CT and CT-perfusion findings of reversible leukoencephalopathy during triple-H therapy for symptomatic subarachnoid hemorrhage-related vasospasm. J Neuroimaging 2006 Apr; 16(2): 170–5
Plana MT, Mane A, Benabarre A, et al. The emergence of darkness phobia in a bipolar patient during quetiapine treatment. J Clin Psychiatry 2006 Apr; 67(4): 673–4
Lin AC-M, Juang G-D, Huang C–H, et al. An unusual cause of iatrogenic bladder rupture. Am J Emerg Med 2006 Jul; 24(4): 512–4
Heinrich TW, Biblo LA, Schneider J. Torsades de pointes associated with ziprasidone. Psychosomatics May–Jun 2006; 47(3): 264–8
Rights and permissions
About this article
Cite this article
First reports of serious adverse drug reactions in recent weeks. Drugs Ther. Perspect 22, 20 (2006). https://doi.org/10.2165/00042310-200622090-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-200622090-00006